Phase 2 Stroke Trial, Recruiting NCT06403267 Sponsor: NoNO Inc. Condition: Stroke
Back to Stroke

Phase 2 Stroke Trial, Recruiting

NCT06403267
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with, or are suspected to have, an acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain) and are being considered for a clot-dissolving medication given through a drip (IV).
  • Your stroke symptoms started (or you were last seen without symptoms) no more than 4.5 hours before being entered into the trial.
  • You are between 18 and 90 years old.
  • Your stroke is causing significant disability, based on a standard stroke severity score measured by the medical team.
  • You have a confirmed or suspected blockage in one of the main blood vessels at the front of the brain, including blockages in both the neck and the brain at the same time.
  • Before your stroke, you were able to look after yourself independently and were not living in a nursing care facility.
  • You (or someone legally able to decide on your behalf) have given consent to take part, following the rules in your country.

Who may not be able to join:

  • Your brain scans show a large area of brain already damaged by the stroke.
  • Your brain scans show any bleeding in the brain.
  • It is unlikely that the study medication can be given before a procedure to physically remove the clot (if that procedure has been planned).
  • You are known or suspected to be pregnant or breastfeeding.
  • Your blood pressure is too low (below 90 mmHg on the top reading).
  • You have previously received the study drug (NoNO-42) for any reason, including taking part in this trial before.
  • You have a serious long-term illness where you are not expected to live for more than 90 days, or which may prevent you from completing the 90-day follow-up appointment.
  • You currently live in a long-term care facility or are a prisoner.
  • You are already taking part in another clinical trial testing a drug, medical device, or a non-standard surgical or brain procedure within the last 30 days (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
NoNO Inc.
Registry
ClinicalTrials.gov
Start date
2 October 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Reducing global disability in participants with acute ischemic stroke (AIS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov